teysuno
nordic group b.v. - tegafur, gimeracil, oteracil - gyomor-daganatok - daganatellenes szerek - teysuno is indicated in adults:- for the treatment of advanced gastric cancer when given in combination with cisplatin (see section 5. - as monotherapy or in combination with oxaliplatin or irinotecan, with or without bevacizumab, for the treatment of patients with metastatic colorectal cancer for whom it is not possible to continue treatment with another fluoropyrimidine due to hand-foot syndrome or cardiovascular toxicity that developed in the adjuvant or metastatic setting.
mitomycin-c kyowa 10 mg por oldatos injekcióhoz
nordic pharma s.r.o. - mitomycin -
mitomycin-c kyowa 20 mg por oldatos injekcióhoz
nordic pharma s.r.o. - mitomycin -
trasylol 500 000 kie/50 ml oldatos infúzió
nordic group b.v. - aprotinin -
veregen 10% kenőcs
nordic pharma s.r.o. - zöld tea levél -
mvabea
janssen-cilag international n.v. - recombinant modified vaccinia ankara bavarian nordic virus encoding the: ebola virus zaire (zebov) mayinga strain glycoprotein (gp); ebola virus sudan gulu strain gp; ebola virus taï forest strain nucleoprotein and the marburg virus musoke strain gp - vérzéses láz, ebola - a vakcinák - active immunization for prevention of disease caused by ebola virus (zaire ebolavirus species) in individuals ≥ 1 year of age.
cetripharm 10 mg filmtabletta
actavis nordic a/s - a cetirizin -
cipropharm 100 mg filmtabletta
actavis nordic a/s - a ciprofloxacin -
cipropharm 250 mg filmtabletta
actavis nordic a/s - a ciprofloxacin -
cipropharm 500 mg filmtabletta
actavis nordic a/s - a ciprofloxacin -